- Joined
- Dec 30, 2010
- Messages
- 12,730
- Points
- 113
MSD's business focuses on prescription medicines, vaccines, biologic therapies, and consumer care and animal health products. Under the new agreement, MSD will invest more than US$250 million, or about S$320 million, over the next 10 years in site improvements at its manufacturing facilities in Tuas, in addition to expanding its biotech operations and boosting its technology capability to support new product launches.
It will also commit to new expenditures of S$700 million on local research activities.
Mr Willie A Deese, president of Merck Manufacturing Division, said: "Signing this agreement today with the EDB is a true investment in our collective future here in Singapore."
- http://www.todayonline.com/Business/EDC111022-0000155/MSD-invests-another-S$1b-here
It will also commit to new expenditures of S$700 million on local research activities.
Mr Willie A Deese, president of Merck Manufacturing Division, said: "Signing this agreement today with the EDB is a true investment in our collective future here in Singapore."
- http://www.todayonline.com/Business/EDC111022-0000155/MSD-invests-another-S$1b-here
